UB Paderborn / Katalog / Suche / in CDI

Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma

Scientific reports, 2019-05, Vol.9 (1), p.7193, Article 7193

2019

Volltextzugriff (PDF)

Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma

Scientific reports, 2021-02, Vol.11 (1), p.2880-2880, Article 2880

2021

Volltextzugriff (PDF)

Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis

International journal of hematology, 2019-07, Vol.110 (1), p.86-94

2019

Volltextzugriff (PDF)

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

International journal of hematology, 2021, Vol.113 (1), p.81-91

2021

Volltextzugriff (PDF)

Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T

International journal of molecular sciences, 2018-01, Vol.19 (2), p.340

2018

Volltextzugriff (PDF)

MET and MST1R as prognostic factors for classical Hodgkin's lymphoma

Modern pathology, 2013-09, Vol.26 (9), p.1172-1182

2013

Volltextzugriff (PDF)

Salvage Esophagectomy for Locoregional Failure After Chemoradiotherapy in Patients With Advanced Esophageal Cancer

The Annals of thoracic surgery, 2012-12, Vol.94 (6), p.1862-1868

2012

Volltextzugriff (PDF)

Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma

Human pathology, 2023-09, Vol.139, p.106-116

2023

Volltextzugriff (PDF)

Usefulness of Interim FDG-PET After Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Sequential Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

International journal of radiation oncology, biology, physics, 2011-09, Vol.81 (1), p.118-125

2011

Volltextzugriff (PDF)

Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

Molecular cancer, 2023-12, Vol.22 (1), p.200-23, Article 200

2023

Volltextzugriff (PDF)

BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis

Modern pathology, 2022-04, Vol.35 (4), p.480-488

2022

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

Lung cancer (Amsterdam, Netherlands), 2009-09, Vol.65 (3), p.351-354

2009

Volltextzugriff (PDF)

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in newly diagnosed multiple myeloma: a systematic review and meta-analysis

European radiology, 2021, Vol.31 (1), p.152-162

2021

Volltextzugriff (PDF)

High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma

International journal of hematology, 2013-02, Vol.97 (2), p.256-262

2013

Volltextzugriff (PDF)

Immunity Against Measles in Korean Autologous Hematopoietic Stem Cell Transplant Recipients

Journal of Korean Medical Science, 2024, 39(28), , pp.1-5

2024

Volltextzugriff (PDF)

CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma

PloS one, 2014-01, Vol.9 (1), p.e87066-e87066

2014

Volltextzugriff (PDF)

Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study

Journal of hematology and oncology, 2021-02, Vol.14 (1), p.25-25, Article 25

2021

Volltextzugriff (PDF)

Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma

International journal of hematology, 2013-02, Vol.97 (2), p.232-239

2013

Volltextzugriff (PDF)

CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

Korean journal of radiology, 2024-04, Vol.25 (4), p.399-402

2024

Volltextzugriff (PDF)

CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

Korean Journal of Radiology, 2024, 25(4), , pp.399-402

2024

Volltextzugriff (PDF)

A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea

Journal of Korean Medical Science, 2024, 39(2), , pp.1-14

2024

Volltextzugriff (PDF)

Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response

Cancer imaging, 2020-01, Vol.20 (1), p.14-14, Article 14

2020

Volltextzugriff (PDF)

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis

Annals of hematology, 2020-06, Vol.99 (6), p.1283-1291

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma

Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma

Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T

MET and MST1R as prognostic factors for classical Hodgkin's lymphoma

Salvage Esophagectomy for Locoregional Failure After Chemoradiotherapy in Patients With Advanced Esophageal Cancer

Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Usefulness of Interim FDG-PET After Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Sequential Induction Chemotherapy Followed by Concurrent Chemoradiotherapy

Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in newly diagnosed multiple myeloma: a systematic review and meta-analysis

High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma

Immunity Against Measles in Korean Autologous Hematopoietic Stem Cell Transplant Recipients

Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results

CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma

Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study

Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma

CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy

A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea

Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis

Suchergebnisse filtern